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ABSTRACT
mRNA homoeostasis is favoured by crosstalk between transcription and degradation machineries. Both the 
Ccr4-Not and the Xrn1-decaysome complexes have been described to influence transcription. While Ccr4- 
Not has been shown to directly stimulate transcription elongation, the information available on how Xrn1 
influences transcription is scarce and contradictory. In this study we have addressed this issue by mapping 
RNA polymerase II (RNA pol II) at high resolution, using CRAC and BioGRO-seq techniques in Saccharomyces 
cerevisiae. We found significant effects of Xrn1 perturbation on RNA pol II profiles across the genome. RNA 
pol II profiles at 5ʹ exhibited significant alterations that were compatible with decreased elongation rates in 
the absence of Xrn1. Nucleosome mapping detected altered chromatin configuration in the gene bodies. We 
also detected accumulation of RNA pol II shortly upstream of polyadenylation sites by CRAC, although not by 
BioGRO-seq, suggesting higher frequency of backtracking before pre-mRNA cleavage. This phenomenon 
was particularly linked to genes with poorly positioned nucleosomes at this position. Accumulation of RNA 
pol II at 3ʹ was also detected in other mRNA decay mutants. According to these and other pieces of evidence, 
Xrn1 seems to influence transcription elongation at least in two ways: by directly favouring elongation rates 
and by a more general mechanism that connects mRNA decay to late elongation.
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Introduction
The dynamic equilibrium that keeps mRNA concentration is 
a balance between synthesis and degradation processes. In the 
classic paradigm, the ‘central dogma’ of molecular biology is 
a linear path in which the mRNA plays a role as an inter-
mediary between genes and proteins. In the recent years our 
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team has helped to demonstrate that there is a general control 
of the total cellular concentration of mRNA ([mRNA] homo-
eostasis) in the yeast Saccharomyces cerevisiae and that it is 
the result of the crosstalk between transcription and degrada-
tion machineries (mRNA-crosstalk) [1]. This involves both 
the mRNA imprinting by RNA binding proteins or base 
methylation, during its synthesis [2], as well as the feedback 
on the transcription machinery exercised by the decaysome 
[1]. Other authors have demonstrated the existence of addi-
tional cross-talk mechanisms in this yeast dependent on the 
Ccr4-Not complex [3] or on the Nab2 mRNA binding protein 
[4]. There are also evidences of the existence of transcription- 
degradation cross-talk in human cells for a subset of mRNAs 
through the Ccr4–Not and Xrn1 complexes [5–7] and during 
viral infections [8]. In fact, for several of these complexes it 
has been demonstrated that there is also an extended connec-
tion to translation of the imprinted mRNAs. Both the Ccr4- 
Not [9] and the Xrn1 (decaysome) complexes [10] have 
a positive role on the translation of certain mRNAs that 
were, presumably, previously imprinted by them during tran-
scription. This points to the existence of a transcription- 
translation cross-talk as well.
RNA pol II transcription is traditionally divided into three 
phases [11]: i) the formation of the PIC (pre-initiation com-
plex) that requires the successive binding of a plethora of 
factors over the basal promotor sequences; ii) the elongation 
phase after the escape of RNA pol II, and associated factors, 
from the promoter while synthesizing the mRNA; and iii) the 
termination phase that is composed by a polyadenylation/ 
cleavage step of the primary transcript and a release of the 
downstream RNA pol II by the concerted action of pause 
sequences and the activity of the Rat1 (Xrn2) exonuclease 
(see 12, 13 for a review).
After initiation, some auxiliary factors remain bound to the 
basal promoter and some others travel with RNA pol II and 
a new set of factors that are required for fast and accurate 
elongation [14–16]. For instance, lack of the elongation factor 
TFIIS provokes increased levels of backtracked RNA pol II 
[17] and specific defects in RP genes [18]. The elongation of 
RNA pol II through chromatin is influenced by the nucleo-
somal organization and specific histone modifications of each 
gene and, at the same time, elongation affects both nucleo-
some positions and histone marks [19]. There is a continuous 
cross-talk between the elongating complex and the chromatin 
template. RNA pol II changes its appearance because of the 
multiple post-translational modifications (phosphorylation 
and others) that the carboxyterminal domain (CTD) of the 
larger subunit (Rpb1) undergoes along the transcription cycle 
[20]. The different phosphorylated forms of CTD make a code 
that is recognized by specific factors along the different elon-
gation sub-phases [20]. The last part of the elongation phase 
starts with the transcription of a sequence that acts as a signal 
for the cutting and polyadenylation machinery [21]. The most 
important sequence element for transcriptional termination is 
the polyadenylation signal (pAS), which, in yeast, consists of 
three sequence elements: the AU-rich efficiency element (EE), 
the A-rich positioning element (PE) and the U-rich elements 
located upstream (UUE) or downstream (DUE) of the clea-
vage site [21,22]. The latter is defined by a pyrimidine fol-
lowed by multiple adenosines Y(A)n [22]. These elements are 
bound, respectively, by the cleavage factor 1B (CF1B, Hpr1), 
1A (CF1A: Clp1, Pcf11, Rna14 & Rna15) and the cleavage and 
polyadenylation factor (CPF: 13 subunits). The RNA is then 
cut, whereupon the coding portion is polyadenylated and the 
3ʹ product rapidly degraded [13,21]. The elongation complex 
undergoes a structural modification during these events. Some 
elongation factors leave the complex shortly before the pAS 
whereas other remain bound [14]. This transition is reflected 
in the profile of active RNA pol II molecules in the close 
vicinity before and after the pAS [23].
Xrn1 is a very large (175 kDa, 1528 amino acids in 
S. cerevisiae) protein with pleiotropic function present in all 
eukaryotes. It was originally cloned as an enhancer of karyo-
gamy defects (KEM1 [24];) and then isolated again as a DNA- 
strand transferase (DST2 [25];) together with DST1 [26], 
a gene that was shown to encode TFIIS [27]. Finally, its 
name was changed into Xrn1 (eXoRriboNuclease 1) because 
of its 5ʹ-3ʹ exonuclease activity [28]. The structure of the 
Klyuveromyces lactis and Drosophila Xrn1 were determined 
in 2011 [29,30]. They showed that the nucleolytic activity is 
on the N-terminal whereas the large C-terminal moiety is not 
directly involved in nuclease activity.
A fundamental question is how Xrn1-decaysome affects 
the transcription process. Comparison of the effects of 
xrn1∆, ccr4∆ and other mRNA decay- and transcription- 
related mutants on GAL1, using computational modelling, 
indicates that Xrn1 and Ccr4 transcriptional functions take 
place in parallel rather than in a concerted manner [31]. The 
Ccr4-Not complex has been shown to bind transcription 
initiation and elongation complexes, and to counteract RNA 
pol II backtracking [9,32]. The information available for the 
Xrn1-decaysome is much less abundant and in some cases, 
contradictory. In order to cast light on how Xrn1 contributes 
to transcription we have performed a series of genome-wide 
and single-gene experiments using various methods to map 
the distribution of RNA pol II under Xrn1-perturbed condi-
tions. Our results indicate that the absence of Xrn1 affects 
transcription during early and late steps of elongation and we 




S. cerevisiae strains used in this study are listed in Table S1. 
Strains were grown at 30°C, with liquid cultures growing in an 
orbital shaking incubator at 180 rpm in YP medium (1% yeast 
extract, 2% peptone) or SC – TRP medium (0.17% yeast 
nitrogen bases (YNB), 0.5% ammonium sulphate and amino 
acids leucine, histidine, lysine and nitrogenous bases adenine 
and uracil) and containing either 2% glucose (YPD) or 2% 
galactose (YPGal) as a carbon source.
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For transcriptional shut-off assays, cells were grown in 
YPGal until reaching an OD600 of 0.2–0.3. At this point, 
4 mM of 4-thiouracil (Sigma) or DMSO was added to the 
media and left to grow for an additional 2 hours until reach-
ing OD600 of approximately 0.5. Then, a sample was taken, 
and immediately after, glucose 4% was added to the culture. 
Samples were taken at the indicated times after glucose 
addition.
For obtaining CRAC samples, strains were grown in SC – 
TRP until an OD600 of 0.5–0.6. In parallel Schizosaccharomyces 
pombe was also grown to an OD600 of 0.5–0.6 in minimal 
media (EMM 0.5X), in order to add 1% to the culture before 
cross-linking as a spike-in. To the XRN1-AID strain 0.2 mM of 
auxin (3-Indoleacetic acid; Sigma-Aldrich) was added to the 
media 30 and 60 minutes before harvesting. To the XRN1-AA 
strain 1 µg/ml of rapamycin (Sigma) was added to the media 
60 minutes before harvesting.
RNA extraction, RT-qPCR and mRNA half-life calculation
Cells were grown to log phase and 10 ml was harvested by 
centrifuging for 2 minutes at 4000 rpm and flash freezing the 
cells in liquid nitrogen. Total RNA was purified using hot 
phenol–chloroform method as described previously [33] and 
reverse-transcribed to cDNA using M-MLV Reverse 
Transcriptase (Promega). A relative real-time quantitative 
PCR was then carried out for all the genes studied (Table 
S2) against SCR1 using SYBR Green Premix Ex Taq (Takara) 
in a Light Cycler 480 II (Roche).
To determine the mRNA half-lives, we used a transcription 
shut-off assay, collecting samples at 5, 20 and 50 minutes after 
glucose addition. mRNA levels were then determined with 
RT-qPCR and half-lives were estimated by calculating the 
time it takes for half of the initial amount of RNA to be 
degraded. Primers used are listed in Table S2.
Chromatin immunoprecipitation (ChIP)
Yeast strains were grown to exponential phase and 50 ml were 
taken for each sample. The ChIP experiments were performed 
as previously described [34], except that anti-Rpb3 (ab81859; 
Abcam), anti-Ser2P (ab5095; Abcam), Anti-Ser5P (ab5131; 
Abcam), anti-Tyr1P (3D12; Merck), anti-H3K4me3 (ab8580; 
Abcam) or anti-H3K36me3 (ab9050; Abcam) antibodies and 
Sheep anti-Mouse IgG Dynabeads (Invitrogen) were used. 
Genes were analysed by quantitative real-time PCR in tripli-
cate using primers listed in Table S2.
The ChIP-seq data was generated in a separate study [31].
CRAC
RNA pol II CRAC was generated and analysed as in [35]. 
Briefly, cells grown until exponential phase were crosslinked 
at UV 254 nm for 50s and harvested by centrifugation. The 
cells were then resuspended in TN150 buffer (50 mM Tris pH 
7.8, 150 mM NaCl, 0.1% NP-40 and 5 mM β- 
mercaptoethanol) supplemented with protease inhibitors 
(complete, Mini, EDTA-free Protease Inhibitor Cocktail). 
This suspension was flash frozen in droplets and cells were 
mechanically broken using the Mixer Mill MM 400. The 
resulting cell ‘powder’ was thawed and treated for one hour 
at 25°C with DNase I (165 U/g of cells). The cells were 
centrifuged and subsequent purifications steps were per-
formed. The purified complexes were eluted with TEV pro-
tease and treated with an RNase cocktail (RNace-IT, Agilent) 
to reduce the size of the nascent RNA. The adaptors were 
modified in order to sequence RNA molecules from the 3′- 
end. The RNA was recovered after proteinase K treatment by 
phenol-chloroform extraction and reverse transcribed using 
specific primers. The resulting cDNA was amplified with 
multiple PCR reactions in a final volume of 25 μl using the 
following conditions: 0.4 μM of each primer, 0.2 mM dNTP, 
2.5 U LA Taq DNA polymerase from Takara, 1x LA PCR 
Buffer II and 2 μl of complementary DNA per reaction with 
the programme: 2 min at 95°C, (30 s at 95°C, 45 s at 58°C, 1 
min at 72°C) × 13 cycles, 5 min at 72°C. All the PCR reactions 
were pooled together and treated with 200 U of Exonuclease 
I (NEB) per ml of PCR reaction for 1 h at 37°C. After 
Exonuclease I inactivation for 20 min at 80°C, DNA was 
purified with PCR clean up columns (NucleoSpin Gel and 
PCR Clean-up, Macherey-Nagel) and sequenced using 
Illumina technology.
BioGRO-seq
The Bio-GRO protocol was essentially as described in [36] for 
tiling array analysis, but modified for high-throughput 
sequencing. For each sample, 100-ml cultures were grown to 
OD600 of 0.55. Cells were collected by centrifugation and 
frozen in liquid nitrogen. Frozen pellets were transferred 
immediately to −20°C. After at least 3 h, cells were thawed 
on ice and permeabilized with 10 ml of 0.5% sarkosyl solu-
tion. RNase trimming was achieved by incubating cells with 
32 µl of RNase A (10 mg/ml) dissolved in 3.2 ml of 0.5% 
sarkosyl solution under agitation conditions for 10 min at 30° 
C. In order to remove RNase, cells were washed three times 
with 50 ml of 0.5% sarkosyl and transferred to an eppendorf 
tube. Cells were resuspended in 120 µl of water plus 5 µl of 
RNase OUT. The run-on reaction was performed by adding 
120 µl of transcription buffer 2.5X (50 mM Tris–HCl, pH 7.7, 
50 mM KCl, 80 mM MgCl2), 16 µl of ACG mix (ATP, CTP, 
GTP, 10 mM each), 6 μL of 0.1 M DTT and 20.25 μL of Bio- 
11-UTP (10 mM, Metkinen) and incubating the mixture at 
30°C for 5 min. The reaction was stopped with 1 mL of cold 
water. After run-on labelling, cells were kept on ice for 5 min 
and harvested by centrifugation. RNA extraction was done 
using the ‘MasterPure Yeast RNA Purification Kit’ (Epicentre) 
following the manufacturer’s instructions. Once extracted, 
contaminating genomic DNA was removed by incubating 
with 2 µl of RNase-free DNase I (Roche) for 30 min at 37° 
C. Purified RNA was resuspended in 32 µl of water and was 
spectrophotometrically quantified. Labelled RNA was sub-
jected to 1 round of affinity purification with streptavidin 
paramagnetic beads (Dynabeads M-280 Streptavidin, 
Invitrogen). Purified labelled RNA was quantified with 
Qubit (Invitrogen) and 5ʹ-OH ends were repaired with PNK 
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prior to library preparation with the NEBNext® Small RNA 
Library Prep Set for Illumina® (Multiplex Compatible).
Nucleosome mapping with MNase
The MNase digestion was performed as described in [37]. 
Briefly, 500 ml of exponentially grown yeast culture was cross- 
linked with formaldehyde. Cells were washed and resus-
pended in Buffer Z2. Zymolyase was added and cells were 
incubated for 30 min at 30°C to obtain spheroplasts. 
Spheroplasts were incubated with different amounts of micro-
coccal nuclease (from 500 to 10 mU). Protein was degraded 
by Proteinase K and DNA was obtained by phenol- 
chloroform-isoamyl extraction and ethanol precipitation. 
Digested DNA was resolved on an agarose gel and the band 
corresponding to mononucleosomes was purified. Naked 
DNA was obtained as before but MNase was added after 
DNA extraction instead of before, and a band with similar 
digestion as the mononucleosomes was purified.
MNase-digested mononucleosomal fragments of DNA 
resulting from wild-type and xrn1Δ strains and the corre-
sponding nucleosome-sized fragments of naked DNA were 
sent to the genomic facility of Centre of Genomic 
Regulation (CRG) in Barcelona to be sequenced. These 
DNA fragments were sequenced using paired-end technology 
from Illumina (HiSeq Sequencing v4 Chemistry with read 
length 50).
High resolution polyA-site mapping
We used unpublished xrn1Δ polyadenylation site mapping 
datasets generated by the internal version of the 3ʹT-fill 
method [37] to map the polyA sites at high resolution. The 
accession number for those data is GSE158548. As a wt refer-
ence, we downloaded and processed raw sequencing files from 
GSE40110.
Bioinformatics
CRAC samples were demultiplexed using the pyBarcodeFilter 
script from the pyCRAC utility suite. Subsequently, the 3′ 
adaptor is clipped with Cutadapt and the resulting insert is 
quality trimmed from the 3′-end using Trimmomatic rolling 
mean clipping (window size = 5, minimum quality = 25). At 
this stage, the pyCRAC script pyFastqDuplicateRemover is 
used to collapse PCR duplicates and ensure each insert is 
represented only once. Each unique insert in our library is 
associated with a six nucleotides random tag within the 5′ 
adaptor. The resulting sequences are reverse complemented 
with Fastx_reverse_- complement (part of the fastx toolkit), 
and mapped to the R64 genome (sgd) with bowtie2 (-N 1 – f) 
[38]. Read counts were normalized relative to reads derived 
from an S. pombe spike-in. The S. pombe spike cells contain 
a non-relevant protein tagged with the same HTP tag that was 
co-purified with the S. cerevisiae sample. We then performed 
a metagene analysis using a package available for Python, 
ngsplot. We obtained the scatterplots, boxplots and density 
plots by counting the number of reads within the ORF of 
a gene using HTSeq, and then plotting this data in R. IGV 
[39] was used to directly compare reads at different positions 
in the genome.
AfterQC v0.9.6 [40] was used with default parameters to do 
the quality control, filtering and trimming of the paired-end 
sequencing data obtained from MNase. The cleaned sequence 
data was aligned to the S. cerevisiae (R64) reference genome 
with bowtie2-2.3.3.1 [38]. Once mapped, the resulting SAM 
files were analysed using DANPOS v2.2.2 [41] in order to 
determine the nucleosome localization, occupancy and fuzzi-
ness across the whole genome in all the analysed strains. 
DANPOS pools the replica of the same condition and can 
use naked data as a background correction.
For BioGRO-seq samples, Trimmomatic [42] was used to 
clip sequencing adapters, trim reads with low quality scores 
and filter reads shorter than 20 bases. High quality reads were 
then aligned to the S. cerevisiae R64 reference genome with 
TopHat2. Normalized average density plots around genomic 
features were generated with the ngs.plot software [43]. The 
RNA-seq mode and the statistical robustness parameter, 
which filters out 0.5% of genes with the most extreme expres-
sion values, were applied to all calculations.
For high-resolution polyA-site mapping, we used 
Trimmomatic to remove sequencing adapters, 5ʹ-end bar-
codes, and 3ʹ-end bases that fell below a minimum quality 
of 3. In order to more precisely remove polyA stretches, we 
used PRINSEQ [44] with the following parameters: min_gc 
20, min_len 20, trim_tail_left 8, trim_tail_right 8, out_format 
3. The remaining high quality reads were mapped to the 
sacCer3 (R64) reference genome with Bowtie2, with default 
parameters. Strand-specific bedgraph files were generated 
with the bamCoverage function from Deeptools [45], with 
the following parameters: bin size 1, normalization rpkm, 
scaling factor 1, ignore missing data false, ignore duplicates 
false, minimum mapping quality 1, offset −1. The last para-
meter was used to collapse the coverage track to the last 3ʹ- 
end base of each read.
Modelling of elongation rates
To estimate the RNA polymerase II elongation rates along the 
genomic region, we divide the region into spatial bins i 2
0; 1; 2; . . .f g where i = 0 corresponds to the Transcription 
Start Site (TSS). The RNA polymerase II hops from bin i to 
i + 1 with rate ki that can be interpreted as the elongation rate 
at that genomic region, and we assume there is no polymerase 
drop off. Let Ri denotes the probability of RNA polymerase II 
occurrence in the spatial bin i where i 2 0; 1; 2; . . .f g. Then, 
the net inflow rate of polymerases into bin i + 1 is 
kiRi 1   Riþ1ð Þ which is proportional to the product of the 
probability that site i is occupied, and site i + 1 is empty. 
Similarly, the net outflow rate of RNA polymerases from bin 
i + 1 is kiþ1Riþ1 1   Riþ2ð Þ. If kTSS is the arrival rate of RNA 
polymerase II to the TSS, one can write the following iterative 
equations based on the same inflow and outflow of poly-
merases at each location
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kTSS 1   R0ð Þ ¼ k0R0 1   R1ð Þ
k0R0 1   R1ð Þ ¼ k1R1ð1   R2Þ
kiRi 1   Riþ1ð Þ ¼ kiþ1Riþ1 1   Riþ2ð Þ:
















and the elongation rate ki normalized with k0is simply equal 
to the ratio R0=Ri. Assuming Ri is proportional to the mean 
number of reads, we plot R0=Ri in Fig. 1D as a function of i.
Western blot
Laemmli-boiled crude extracts were run on a SDS- 
polyacrylamide gel and transferred to nylon membranes 
(Hybond-ECL). After blocking with Tris-buffered saline con-
taining 0.1% Tween 20 and 5% milk, the following primary 
antibodies were used: anti-FLAG M2 (Sigma-Aldrich), anti- 
GFP (Roche) and anti-L1. Finally, the membrane was incu-
bated with peroxidase-conjugated goat anti-mouse IgG and 
proteins were detected using a chemiluminescence detection 
kit (Super-Signal West Pico, Pierce) and a ChemiDocTM MP 
system (Bio-Rad).
Sucrose gradient centrifugation
For polysome preparations 200 ml cultures were grown in 
YPD and harvested at an OD600 between 0.5 and 1. 
Cycloheximide was added to a final concentration of 
0.1 mg/ml before harvesting for 10 min. Cell extracts were 
obtained by adding lysis buffer (10 mM Tris-HCl (pH 7.5), 
100 mM NaCl, 30 mM and 0.2 mg/ml of heparin) and glass 
beads, and vortexing for 8 min at 4°C. The supernatant was 
recovered after centrifugation and flash frozen. Thawed 
extracts (10 absorption units at 260 nm) were layered onto 
11.2 ml of 7 to 50% linear sucrose gradients that were pre-
pared in 50 mM Tris-acetate (pH 7.5), 50 mM NH4Cl, 12 mM 
MgCl2, 1 mM dithiothreitol. The gradients were centrifuged 
at 39,000 rpm in a Beckman SW41 rotor at 4°C for 2 h 
45 min. Gradient analysis was performed with an ISCO UV- 
6 gradient collector and continuously monitored at 254 nm. 
Fractions were collected every 30 s for 9 min (18 in total).
For western analysis, proteins (0.5 ml of each fraction) were 
precipitated by addition of trichloroacetic acid to a final concen-
tration of 10%, followed by incubation on ice for 10 min. 
Proteins were pelleted by centrifugation for 10 min at 4°C. 
Pellets were washed twice with 1 ml of ice-cold acetone and 
finally resuspended in 20 µl of 2X Laemmli buffer. Every two 
fractions were mixed together and aliquots of 20 µl were loaded 
onto 10% SDS-polyacrylamide gels and analysed by western blot.
Results
CRAC experiments confirm that lack of Xrn1 decreases 
transcription rates
Conflicting results on the effect of the xrn1∆ mutation on 
transcription rates have been described, based on different 
experimental approaches (Fig S1A-B). We have previously 
shown that genomic run-on (GRO) analyses indicate 
a global negative effect of xrn1∆ on transcription rates across 
the genome [1]. In contrast, results obtained after RNA meta-
bolic labelling (cDTA) with 4-thiouracil (4-tU) were inter-
preted to support a positive effect of xrn1∆ on transcription 
rates [46].
To address this apparent contradiction, we adopted a third 
experimental approach, using RNA pol II CRAC to map the 
distribution of elongating RNA pol II molecules at nucleotide 
resolution. For a quantitative analysis of the effect of the 
xrn1∆ mutation we normalized our data to a spike in obtained 
from the addition to each sample of an equivalent amount of 
S.pombe cells expressing a tagged protein that could be co- 
purified with yeast RNA Pol II [47]. This analysis confirmed 
a very significant negative effect of xrn1∆ on transcription 
rates (Fig S1C-E). The similarity between CRAC and GRO 
data extended to the dependency of the xrn1∆ effect on 
transcription levels. Both in GRO and CRAC experiments, 
the negative effect caused by the mutation was slightly stron-
ger for highly transcribed genes (Fig S1F).
We considered the possibility that the differences with the 
metabolic labelling study of Sun et al [46] might be due to an 
effect of 4-tU on mRNA stability. Indeed, although in that 
study 4-tU was used to estimate transcription levels, 
a significant fraction of 4-tU containing RNAs after the 6 min-
utes labelling step might be post-transcriptional and subject to 
degradation. We set out to assess whether degradation of these 
4tU labelled RNAs is delayed in xrn1∆ cell, which could lead to 
an overestimation of transcription levels in these cells.
To this end, we measured the stability of RNAs derived 
from genes of the galactose regulon with a glucose-shutdown 
approach. As shown in Figure S2A, the half-life of 4-tU 
containing RNAs is significantly increased in xrn1∆ cells. 
This suggests that 4-tU inhibits, in vivo, the exosome- 
dependent 3ʹ-5ʹ degradation pathway that takes over mRNA 
degradation in cells defective for the 5ʹ-3ʹ, Xrn1-dependent 
pathway. Consistent with this notion, levels of ncRNAs that 
are degraded by the exosome increased in wild-type cells 
treated with 4-tU (Fig S2C). These results strongly suggest 
that the increase in 4tU-labelled RNAs levels, previously 
observed in the xrn1∆ mutant by Sun et al [46] might be 
due to the stabilization of these RNAs rather than to increased 
transcription rates in xrn1∆ cells.
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Xrn1 regulates transcription elongation at the 5ʹ of genes
In addition to an overall effect on the number of transcribing 
RNA pol II molecules, lack of Xrn1 produced significantly 
altered RNA pol II profiles across the genome. Metagene 
analyses showed an increase in the density of elongating 
RNA pol II molecules mapped in the wild type shortly down-
stream of the transcription start site (TSS) and a progressive 
decline afterwards (Fig. 1A). This decline was less pronounced 
in xrn1∆, which can be appreciated in the difference in slopes 
of the two strains (50% reduction of the wild-type slope in 
xrn1∆). The difference in slope was particularly clear in highly 
transcribed genes and those containing canonical TATA ele-
ments, but was also easily detected in other categories of genes 
(Fig. 1A, Fig S3).
Different RNA pol II profiles between wild-type and xrn1∆ 
5ʹ metagenes were also detected after performing a high- 
resolution genomic run-on analysis (BioGROseq) (Fig. 1B). 
Fast depletion of Xrn1, using an AID degron approach (Fig 
S4), also provoked a change in the CRAC RNA pol II profile 
in the 5ʹ end metagenes, exhibiting a decrease in the slope 
which is visible after just 30 min depletion (Fig. 1C).
Figure 1. Xrn1 perturbation alters RNA pol II profiles downstream of the TSS. A) A metagene plot of the CRAC data for all canonical TATA-containing genes 
aligned by their transcription start site (TSS) shows that there is a global reduction in RNA bound to total RNA pol II and a decrease in the slope in a xrn1∆ strain (in 
orange) compared to the wild type (in green). Similar plots for all genes and for some specific gene groups are shown in Fig S3. B) A similar metagen plot of BioGRO- 
seq data for all TATA genes shows the same effect as in A for the nascent mRNA produced by active RNA pol II. C) The fast depletion of Xrn1 using the auxin-degron 
system shows a progressive change in the slope of the CRAC data of all TATA genes but with a small increase in the global number of reads. D) Estimation of 
elongation rates from the CRAC data after fast depletion shown in C, after solving iterative equations based on the same inflow and outflow of polymerases at each 
location (see Methods). E) The fast depletion of Xrn1 from the nucleus using the anchor-away protocol (orange) also shows a change in the slope compared to the 
wild type (green). A similar plot for all genes is shown in Fig S5B.
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These results support an influence of Xrn1 on transcription 
elongation, as previously proposed [1,31,48]. Changes in the 
slope of RNA pol II profiles has been usually interpreted as 
the consequence of alterations in RNA pol II processivity. 
According to this, the less negative slopes in Xrn1-perturbed 
strains would indicate increased processivity and would 
involve a negative influence of Xrn1 on this aspect of tran-
scription elongation. Alternatively, the different slope detected 
in Xrn1-perturbed cells may indicate alterations in elongation 
rates, as we have already found for xrn1∆ in kinetic experi-
ments with a galactose-controlled long gene [31]. In order to 
test this last possibility, we decided to model our Xrn1-degron 
CRAC data, following an iterative equation approach. As 
shown in Fig. 1D, in both conditions (depleted and non- 
depleted) estimated elongation rates dropped at the same 
position from TSS (+80 bp). From there on, our model esti-
mated a progressive increase in the elongation rate for the 
non-depleted condition. In contrast, this acceleration was 
almost absent in the Xrn1-depleted condition (Fig. 1D).
In the case of Xrn1-depleted data, there was no overall 
decrease in the number of reads as in xrn1∆ (compare Fig. 
1A–C). This is compatible with a scenario where xrn1∆ cells 
exhibit both elongation and initiation defects, the latter being 
responsible for the general decrease in the number of tran-
scribing RNA pol II molecules. In contrast, Xrn1 depletion by 
the AID degron system would provoke just the elongation 
defect, producing no decrease but a slight accumulation of 
RNA pol II molecules on the gene body, likely as 
a consequence of its reduced elongation rate. According to 
this view, the initiation defect detected in xrn1∆ might be 
related, at least partially, to the downregulation of RNA pol II- 
dependent transcription caused by slow growth [36,48].
RNA pol II CRAC analysis was also performed after deplet-
ing the nuclear pool of Xrn1, using an anchor-away approach 
(Fig S5). After 1 h incubation with rapamycin, we found a slight 
decrease in the slope of the RNA pol II profile at 5ʹ (Fig. 1E), 
similar to the one produced by total Xrn1 depletion (compare 
Fig. 1C–E, and S3A to S5B). This modest effect detected might 
suggest that the functional influence of Xrn1 on transcription 
elongation depends on its presence in the nucleus. However, 
we should be very cautious when interpreting these results, 
since we did not find any change in the slope when longer 
treatments were performed (2 and 5 hours in the presence of 
rapamycin) and, therefore, we cannot rule out that nuclear 
Xrn1 depletion was partial and transient.
Lack of Xrn1 produced changes in nucleosome density on 
gene bodies
We have seen that the change in the slope of CRAC profiles at 
5ʹ metagenes produced by the lack of Xrn1 indicates general 
alteration of transcription elongation that are compatible with 
either increased RNA pol II processivity or decreased elonga-
tion rate. Any of these two possibilities would involve 
increased competition for occupancy between elongating 
RNA pol II molecules and nucleosomes along gene bodies. 
Slower elongation would involve higher dwell time for 
elongating RNA pol II molecules and, as a consequence of 
it, increased competition with nucleosomes. Increased proces-
sivity would also predict a higher number of elongating RNA 
pol II molecules competing with nucleosomes in distal 
positions.
In order to test this prediction we generated nucleosomal 
maps of cells lacking Xrn1, using an MNase-seq approach 
optimized for detecting elongation-related phenomena [49]. 
These maps showed increased occupancy of the two nucleo-
somes flanking the nucleosome-depleted region (NDR) just 
upstream of the TSS in xrn1∆ (Fig. 2A). This may be indica-
tive of a lower frequency of PIC assembly, as a consequence of 
the competition between PIC assembly and nucleosome +1 
[50], and is consistent with our hypothesis of overall decrease 
in transcription initiation in xrn1∆. Alternatively, this might 
also be consistent with less pausing in the early stages of 
elongation.
We also detected decreased occupancy of nucleosomes in 
the gene body, downstream of nucleosome +2 (Fig. 2A). 
Metagenes obtained after aligning genes to the polyadenyla-
tion site (pAS) allowed the visualization of nucleosome occu-
pancy reduction in xrn1∆ along the whole gene body (Fig. 
2B). Independently of gene length, nucleosome occupancy of 
xrn1∆ started to be lower than the wild type around positions 
+400 (Fig S6) and remained depleted until the 3ʹ end of the 
gene body (Fig. 2B). This is fully consistent with the alteration 
in transcription elongation deduced from the lower slope 
observed in RNA pol II CRAC profiles after Xrn1 perturba-
tion. For instance, after 1 h of nuclear Xrn1 depletion, the 
profile of RNA pol II CRAC progressively separated from the 
untreated sample, decreased during the first 400 bp down-
stream of the TSS, independently of the gene length, and then 
remained constant until the pAS (Fig S7). This parallelism 
between increased density of RNA pol II molecules and 
reduced nucleosome occupancy is consistent with alterations 
of RNA pol II elongation dynamics caused by Xrn1 
perturbations.
We wondered if the detected alteration in elongation 
would be reflected in the distribution of actively elongating 
RNA pol II molecules across the nucleosomes located in 
different positions of the gene body. We compiled the whole 
set of BioGROseq signals of +1 to +4 nucleosomes from the 
TSS, in order to get the average of each position in wild type 
and xrn1∆ cells, and represented them after alignment to the 
nucleosome dyad axis. We found no differences for the profile 
of +1 nucleosomes, suggesting that dynamics of the first 
nucleosome (usually occupying the TSS) during transcription 
initiation was not affected by lack of Xrn1 (Fig. 2C). In 
contrast, we detected significant differences between xrn1∆ 
and the wild type for nucleosomes +2, +3 and +4. Higher 
density of BioGROseq signals were found before the dyad axis 
of these nucleosomes in the wild type, reflecting the accumu-
lation of elongating RNA pol II just before the dyad of gene 
body nucleosomes. In xrn1∆ the profiles of actively transcrib-
ing RNA pol II molecules across +2, +3 and +4 nucleosomes 
were wider and shifted to the 3ʹ, confirming a different 
dynamic of elongation immediately downstream of TSS 
(Fig. 2C).
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Xrn1 perturbation produces prominent pausing of RNA 
Pol II upstream of the pA site
RNA pol II CRAC also exhibited clear differences between 
wild-type and xrn1∆ cells at the 3ʹ end of genes. Prominent 
peaks were found at this region in xrn1∆, usually located 
shortly upstream of the pA (Fig S8). Metagene analysis con-
firmed the presence of these 3ʹ peaks in different gene cate-
gories (Fig. 3A, S9A-C), particularly in highly transcribed 
genes (Fig S9D-G). Albeit with different intensity, the vast 
majority of genes showed higher RNA pol II CRAC values in 
this region than the wild-type, with the maximal differential 
signal mapping 40 bp upstream of the pAS (Fig. 3B-C).
In contrast, no peak was found in this region in the 
BioGROseq profiles of xrn1∆ (Fig. 3D). Since transcriptional run- 
on cannot detect backtracked RNA pol II molecules, we consider 
highly probable that the detected peak represents inactive mole-
cules unable to move forward during very late elongation.
In order to confirm that the reads conforming the detected 
CRAC peaks corresponded to nascent RNA, all reads that 
contain a deletion (indicating the presence of a crosslink) 
were selected and a dataset containing only the position of 
the deletions (instead of the whole read) was generated. Genes 
showing prominent peaks were examined and showed pat-
terns identical to those seen with all the reads (Figure S10).
This accumulation of RNA pol II at the 3ʹ was also detected 
in metagenes after fast depletion of Xrn1 (Fig. 3E, S11A), as it 
happened in almost every gene (Fig. 3F, S10, S11B). We 
found, also in this case, that the maximal differential CRAC 
signal mapped 40 bp upstream of the pAS (Fig. 3G, S11C). 
These results strongly indicate a functional influence of Xrn1 
in late elongation, that is not due to the slow growth pheno-
type of xrn1∆. However, we did not detect any RNA pol II 
CRAC signal accumulation at the 3ʹ end after depleting 
nuclear Xrn1 with the anchor-away technique, suggesting 
that this influence of Xrn1 on late elongation might not 
require its presence in the nucleus (Fig. 3H).
Since the inactive RNA pol II peak at the 3ʹ does not seem 
to be directly related to nuclear Xrn1 but to lack of Xrn1 in 
the cell, we wondered if other perturbations of mRNA decay 
might produce similar results. We mapped total RNA pol II in 
dhh1∆ and ccr4∆, two mutants lacking factors involved in 
decapping and deadenylation during mRNA decay, in 
a genome wide manner by ChIP seq. Metagenes showed 
increased levels of RNA pol II at 3ʹ, around the pAS, in the 
two mutants, similarly to xrn1∆ (Fig S12A-C), suggesting that 
Figure 2. Lack of Xrn1 changes the chromatin landscape and the distribution of active RNA pol II molecules through nucleosomes. A) Metagene analysis of 
the MNase-seq data shows increased occupancy of the nucleosomes flanking the TSS and decreased occupancy of nucleosomes in the gene body in a xrn1∆ strain (in 
blue) compared to the wild type (orange). The red arrow indicates where the profile changes from higher nucleosome occupancy to lower occupancy in xrn1∆. B) The 
same analysis as in A but around the polyA site (pAS) and dividing the genes depending on the gene length into 3 groups according to gene length. The red arrows 
indicate the intersection between wild-type and xrn1∆ profiles. C) Compiled BioGRO-seq signals for the wild type and xrn1∆ in +1, +2, +3 and +4 nucleosomes 
aligned to the dyad axis. Profiles of active RNA pol II were unchanged in the +1 nucleosome but were wider and shifted to the 3ʹ in xrn1∆ in the subsequent 
nucleosomes (+2, +3 and +4).
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accumulation of RNA pol II at 3ʹ is a response to mRNA 
decay impairment. In all cases the intensity of RNA pol II 
accumulation increased with the transcription rate (Fig 
S12D-F).
We wondered whether the accumulation of inactive RNA 
pol II molecules at 3ʹ would involve alterations in the poly-
adenylation site selection. To test this, we processed raw data 
of poly(A) 3ʹT-fill experiments in xrn1∆ produced by Vicent 
Pelechano in Lars Steinmetz lab, who kindly provided them 
for this study. The overall distribution of mapped polyA sites 
in xrn1∆ was similar to the wild type, although a slight 20–30 
bp shift to 3ʹ was detected (Fig S13A-B). However, the mag-
nitude of this shift did not correlate to the intensity of RNA 
pol II accumulation at 3ʹ, suggesting that these two phenom-
enon are not directly linked (Fig S13C).
Late elongation of regulatory genes with poor 
nucleosome positioning at 3ʹ is particularly sensitive to 
lack of Xrn1
Transcription elongation defects can be due to impaired func-
tion of the elongation complex or to altered chromatin 
Figure 3. Xrn1 perturbation produces an alteration of total RNA pol II profiles at the 3ʹ end of genes. A) Metagene analysis of RNA pol II-CRAC profiles in 
xrn1∆ (orange) compared to the wild type (green) around the polyA site (pAS) of TATA-containing genes. B) Heatmap of the xrn1∆/wt ratio of CRAC data, showing 
a widespread increase in the number of xrn1∆ reads just before the pAS (in red). Genes are ordered regarding the peak intensity. C) Metagene representing the mean 
of all genes shown in the previous heatmap. D) Metagene plot of the BioGRO-seq data in wild-type and xrn1∆ cells, showing that there is no accumulation of active 
RNA pol II in xrn1∆ at the 3ʹ end of TATA-containing genes. E) Metagene analysis of RNA pol II-CRAC profiles in Xrn1-Anchor away after 0 min (green), 30 min (red) 
and 60 min (burgundy) of Xrn1 depletion around the polyA site (pAS) of TATA-containing genes. F) Heat map of ratios, as in B, but 30 minutes after Xrn1 depletion 
(auxin-degron CRAC-seq data) divided by data before depletion. G) Metagene representing the mean of all genes shown in the previous heatmap. H) Metagene 
analysis of RNA pol II-CRAC profiles in Xrn1-Anchor away, showing no accumulation RNA pol II at the 3ʹ end of genes after nuclear Xrn1 depletion.
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dynamics in front of elongating RNA pol II. Accumulation of 
inactive RNA pol II 40 bp upstream of the pAS implies that it 
takes place in the 3ʹ nucleosome-depleted region that char-
acterizes RNA pol II-dependent genes. No significant altera-
tions of nucleosome maps were detected in xrn1∆ cells in that 
specific position, in comparison to the wild type (Fig. 2B). We 
also found no abnormalities in the main histone marks asso-
ciated to the 5ʹ and 3ʹ chromatin dynamics during transcrip-
tion. Histone H3 K4-trimethylation, a mark linked with 
initiation and early elongation, was not significantly changed 
in xrn1∆ in either a highly transcribed gene (RPS3) or 
a moderately expressed one (SWD1) (Fig S14A-B). Similarly, 
the profile of histone H3 K36-trimethylation, a modification 
linked to later steps of elongation, did not significantly change 
in any of the tested genes (Fig S14 C-D).
Since we did not find any significant change of 3ʹ chroma-
tin in xrn1∆, we focused on the elongation complex. 
Transitions during transcription elongation are linked to 
modifications of the phosphorylation state of Rpb1 CTD, 
particularly in Ser2 residues [51]. Tyr 1 phosphorylation has 
been also involved in termination [52]. We analysed it by 
ChIP in three different genes. Two of them exhibited signifi-
cant peaks in 3ʹ although with different transcription rates: 
RPL40A (highly transcribed) and FLC2 (moderately tran-
scribed). A third gene, RPS3, was selected for being highly 
transcribed, although it showed much less accumulation of 
RNA pol II at 3ʹ in xrn1∆. Ser2 phosphorylation is the CTD 
mark most clearly associated to the elongation step of tran-
scription. We found some alterations in the Ser2 profiles of 
the three genes tested in xrn1∆, since higher levels of phos-
phorylation were detected in the mutant in all positions but 
the TSS (Fig. 4B). In contrast, lower levels of Tyr1- 
phosphorylation was found in FLC2 and in some amplicons 
of the two other genes tested (Fig. 4C).
Ser2 and Tyr1 phosphorylation of Rpb1 CTD has been 
linked to the recruitment of 3ʹ pre-mRNA cleavage factors 
[51]. Thus, we investigated whether lack of Xrn1 involved 
abnormal recruitment of CF-IA. We found significantly 
increased binding of Rna15 to amplicons located in the 3ʹ 
end of these and several other genes (Fig. 4D and S15A-B). 
We also found increased levels of Rna14 at the 3ʹ end of RPS3 
(Fig S15C). These results indicate that in Xrn1-deficient cells 
the RNA pol II elongation complex is altered in two aspects 
related to 3ʹ mRNA processing: CTD phosphorylation and the 
binding of CF-IA. This suggests that the accumulation of 
inactive RNA pol II molecules at the 3ʹ end of genes might 
be the consequence of defective elongation complexes. 
However, this defect seems to be general and not specific of 
those genes showing the most prominent peaks.
Since the alterations in the elongation complex did not 
explain the intensity of 3ʹ peaks we wondered if the chromatin 
configuration of each gene might. We obtained metagene 
nucleosomal profiles of the 20% top and bottom genes in 
the distribution of peak intensities shown in Fig. 3B. Clear 
differences were detected in the wild type (Fig. 5A). Those 
genes with the most significant peaks showed a less defined 
nucleosomal pattern around the polyA site, and a wider and 
less-sharp nucleosome depleted region than bottom genes 
(Fig. 5A). Similar differences between top and bottom genes 
were detected in xrn1∆, indicating that these differences were 
neither enhanced nor suppressed by lack of Xrn1 (Fig S16).
We were unable to find any specific DNA motif differen-
tially present in top genes versus bottom ones. However, the 
nucleotide composition of the pAS region exhibited some 
differences. Top genes showed a significant enrichment for 
T nucleotides in the pAS, whereas bottom genes exhibited 
higher frequency of C nucleotides in the same region (Fig. 
5C). This difference in sequence composition may explain the 
dissimilar nucleosomal organization of top and bottom genes 
around the pAS.
These results suggest that those genes with less positioned 
nucleosomes at their 3ʹ end are more sensitive to the altera-
tions in late elongation caused by lack of Xrn1. In order to 
explore a possible functional consequence of this scenario we 
analysed the GO categories enriched in top genes. We found 
that most of the enriched GO terms were connected to the 
regulation of biological processes, suggesting that regulatory 
genes might be particularly sensitive to this phenomenon.
Discussion
We have previously shown that lack of Xrn1 produced down-
regulation of transcription across the genome [1]. In an inde-
pendent work the group of E. Young also found a positive role 
for Xrn1 in the transcription of Snf1-dependent genes [53]. 
However, a different study, based on RNA metabolic labelling, 
described apparently opposite effects of xrn1∆ on transcrip-
tion [46]. In this work, using different technical approaches, 
we demonstrate that Xrn1 perturbation originates significant 
negative alterations of RNA pol II distribution and, therefore, 
we confirm that Xrn1 plays a general positive contribution to 
gene transcription. Our experimental work suggests that 
metabolic labelling with 4-tU might introduce experimental 
noise in transcription rates calculations, particularly when the 
5´ to 3ʹ pathway of mRNA degradation is impaired, as it 
happens in xrn1∆. Previous results of Xrn1 were also based 
on the study of mutant cells lacking Xrn1, which exhibit 
pleiotropic phenotypes, including large cell volume and slow 
growth, which can indirectly affect transcription [48,54]. In 
this work, we made use of an auxin-degron approach to 
decrease the risks of indirect effects of xrn1∆.
We also show in this study that Xrn1 perturbation speci-
fically impairs transcription elongation at 5ʹ ends, shortly after 
initiation, and at 3ʹ ends, immediately before pre-mRNA 
cleavage. Similar observations have been very recently pub-
lished after mapping RNA pol II distribution in xrn1∆ cells by 
NET-seq [55]. At the 5ʹ end of gene bodies we observed that 
Xrn1 perturbations produced a change in the slope of the 
RNA pol II profiles obtained either with CRAC or 
BioGROseq. This change can be interpreted as the conse-
quence of increased RNA pol II processivity (reduction in 
drop-off during elongation). This interpretation is contradic-
tory with a positive role of Xrn1 in mRNA buffering, unless 
Xrn1 favoured premature termination of non-productive 
elongating RNA pol II molecules. For instance, uncapped 
nascent RNA transcripts might be removed by Xrn1 during 
early elongation, like Rat1 does with nascent transcripts after 
pre-mRNA cleavage at 3ʹ [56].
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Alternatively, the 50% reduction in slope produced by 
xrn1∆ can be interpreted as a decreased in RNA pol II elon-
gation speed. This interpretation is in total agreement with 
the 50% reduction in RNA pol II elongation speed measured 
by us with the GAL1p-YLR454w system [31]. It also fits with 
the enhanced recruitment of TFIIS across the genome 
observed in xrn1∆ cells, which indicates higher frequency of 
RNA pol II backtracking in the absence of Xrn1 [31].
We also found that nucleosome occupancy was decreased 
after the +2 position in the gene body, and that the high- 
resolution distribution of the BioGROseq signal across these 
nucleosomes was significantly altered in xrn1∆. This paralle-
lism between RNA pol II elongation defects and altered chro-
matin in gene bodies does not tell us whether there is 
a causative relation between them. However, these results 
shed light on the contribution of Xrn1 to chromatin transcrip-
tion from two complementary aspects (nucleosome position-
ing and RNA pol II activity) and suggest a model were lack of 
Xrn1 makes the elongation complex unable to keep the wild- 
type elongation rate, due to different interaction dynamics 
between RNA pol II and the nucleosome. In this sense, 
Xrn1 might behave as other elongation factors that modulate 
RNA pol II pausing through nucleosomes [57].
At the 3ʹ end of gene bodies we observed the accumulation 
of RNA pol II CRAC signal 40 bp upstream of pAS in Xrn1- 
deficient cells. This indicates a strong pausing phenomenon. 
Lack of a similar signal in BioGROseq profiles, based on the 
run-on capacity of the mapped molecules, suggests that RNA 
pol II paused at this position become backtracked. This posi-
tion of the gene body is a key point where the elongation 
complex undergoes severe changes. Some factors that travel 
with RNA pol II during elongation leave the complex at this 
point whereas others remain bound until termination [14]. 
This restructuration is coupled to the 3ʹ processing of pre- 
mRNA, which is cleaved by CF-IA from the CTD. Arrest of 
RNA pol II at this point is likely reflecting abnormal dynamics 
Figure 4. Lack of Xrn1 alters Ser2 and Tyr1 phosphorylation of RNA pol II CTD and enhances the binding of CF-IA. A) Snapshot of 3 different genes (from left 
to right: FLC2, RPL40A and RPS3) showing the CRAC signal in the wild type and xrn1∆ throughout the gene. The red arrow indicates the presence of an increased 3´ 
peak in the mutant. At the bottom we indicate with numbers the amplicons analysed in the subsequent ChIP experiments. B) Anti-phosphorylated Ser2-CTD ChIP 
experiment show slightly increased levels of this CTD modification in xrn1∆ strain in all three genes. We represent IP signal normalized by Rpb3 ChIP, obtained with 
the same extracts in parallel. C) Anti-phosphorylated Tyr1-CTD ChIP, normalized by Rpb3 ChIP, for the same genes. Slight decrease in Tyr1 phosphorylation was 
detected. D) Anti-Rna15-TAP ChIP shows increased binding of Rna15 to 3ʹ in xrn1∆ cells. In all cases the mean and standard deviation of three biological replicates is 
shown. All ChIP experiments were performed using the TAP-tagged Rna15 strain. * stands for a statistically significant difference between wt and mutant (Student’s 
t-test with p < 0.05).
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of the elongation complex in this key step. Recruitment of CF- 
IA to the CTD during elongation is regulated by Ser2 phos-
phorylation [51]. We found altered levels of this phosphoryla-
tion mark and enhanced binding of CF-IA to the elongation 
complex in Xrn1-perturbed cells. This suggests that the altera-
tion of late elongation that we have detected is due to changes 
in the elongation complex that, later on, provokes RNA pol II 
arrest during the elongation/termination transition.
Although frequent, the peaks of RNA pol II shown by 
xrn1∆ at 3ʹ were not equally prominent in all genes. This 
specificity seems not to be related to the alterations of CTD 
phosphorylation marks or to the increased binding of CF-IA, 
since these changes also take place in genes with low accu-
mulation of RNA pol II at 3ʹ gene ends. Our nucleosome 
maps indicate that these peaks are favoured in genes with 
poor nucleosome positioning at 3ʹ. So, it seems that these 
peaks result from the combination of altered elongation com-
plexes within a certain chromatin environment. Intriguingly, 
genes with significant RNA pol II accumulation at 3ʹ are 
enriched in regulatory functions. This opens an interesting 
scenario, where genes with regulatory functions may reduce 
noise by mRNA buffering due to a particularly sensitive 
response to the mRNA decay/transcription crosstalk.
In principle, the two elongation phenotypes that we have 
described might be caused by a single molecular event derived 
from Xrn1 perturbation. However, several pieces of informa-
tion suggest that they are partially independent and that only 
the alteration of elongation speed is directly related to 
a nuclear function of Xrn1. We have previously shown in 
individual genes that this function of Xrn1 is independent of 
Ccr4, as it is the genome-wide enhancement of TFIIS recruit-
ment produced by xrn1∆ [48]. The results of the Xrn1 
anchor-away experiments must be interpreted cautiously 
(see above) but depletion of the nuclear Xrn1 pool seemed 
to confirm that Xrn1 early elongation function is related to its 
presence in the nucleus, whereas the late elongation function 
is not. In fact, accumulation of RNA pol II at 3ʹ was also 
detected in other mRNA decay mutants, like dhh1∆ and 
ccr4∆, suggesting that the late elongation defect caused by 
lack of Xrn1 was mediated by its impact on mRNA decay. 
Impairment of mRNA degradation may cause an alteration in 
the circulation of factors between the cytoplasm and the 
nucleus, provoking a change in the composition of the RNA 
pol II elongation complex and/or in the nuclear availability of 
factors that regulate late elongation (see graphical abstract). 
This phenomenon would be particularly relevant for genes 
Figure 5. Genes with poor nucleosome positioning at 3ʹ in wild-type cells are more sensitive to RNA pol II arrest in xrn1∆. A) Nucleosomal maps (in wild- 
type cells) of the pAS regions of genes showing different intensity of RNA pol II peaks at 3ʹ caused by xrn1∆, obtained by resistance to micrococcal nuclease. 
Metagenes were calculated for two sets of genes from the distribution shown in Fig 3C: genes ranking in the 20% top (top genes) and 20% bottom (bottom genes). 
B) Frequency of C and T in the nucleotide composition of top and bottom genes. 10 nucleotide moving average is shown. C) Significance of the difference in C and 
T nucleotide composition between top and bottom genes, calculated by a Chi square test. D) Functional GO categories enriched in top genes.
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with poorly positioned nucleosomes at 3ʹ. According to this 
view, Xrn1 would influence transcription elongation at least in 
two ways: by directly influencing elongation speed and by 
a more general mechanism that connects mRNA decay and 
late elongation.
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